Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest Neuromodulation Stories

2012-12-07 04:21:02

NATICK, Mass., Dec. 7, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval and has begun the European market launch of the Precision Spectra(TM) Spinal Cord Stimulator (SCS) System. The Precision Spectra System is the world's first and only SCS system with 32 contacts and 32 dedicated power sources and is designed to provide improved pain relief to a wide range of patients who suffer from chronic pain. The first commercial implant of the Precision...

2012-12-06 08:26:13

MINNEAPOLIS, Dec. 6, 2012 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ:UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today highlighted results of a study that compared the cost effectiveness of neuromodulation therapies for Overactive Bladder (OAB) patients over two years of treatment. The study compared percutaneous tibial nerve stimulation (PTNS) delivered via Uroplasty's Urgent(®) PC...

2012-11-13 12:30:13

FORT BRAGG, N.C., Nov. 13, 2012 /PRNewswire/ -- The United States Army is taking action to help wounded soldiers avoid the added crisis of a prescription drug addiction. Doctors and researchers are now emphasizing providing non-pharmaceutical treatment for pain related injuries. Spinal pain is the number one cause for a soldier's discharge, but thanks to Operation OpiodSAFE, veterans are getting back into the field with the help of new programs and technologies developed to improve function...

2012-10-30 07:26:05

ALBANY, New York, October 30, 2012 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Neuromodulation Devices Market - Global Industry Analysis, Size, Share and Forecast, 2012 - 2018 [http://www.transparencymarketresearch.com/global-neuromodulation-devices-market.html ]," the global neuromodulation devices market was valued at USD 2,758 million in 2011 and is expected to grow at a CAGR of 14.4%...

2012-09-27 22:21:42

NATICK, Mass., Sept. 28, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) received CE Mark approval for use of its Vercise(TM) Deep Brain Stimulation (DBS) System for the treatment of Parkinson's disease. The Vercise DBS System is the first and only commercially available DBS system to incorporate multiple independent current control, which is designed to selectively stimulate targeted areas in the brain. This system is an innovative technology that is designed to provide...

2012-09-26 02:25:55

MINNEAPOLIS, Sept. 26, 2012 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that ConnectiCare of the Emblem Health family of insurers began coverage of percutaneous tibial nerve stimulation (PTNS) using its Urgent® PC neuromodulation system for the treatment of the symptoms of overactive bladder syndrome (OAB). Effective immediately, approximately...

2012-09-04 02:28:27

MINNEAPOLIS, Sept. 4, 2012 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that its Urgent® PC Neuromodulation System will be included as part of a neuromodulation workshop at the Annual Meeting of the International Urogynecological Association (IUGA) in Brisbane, Australia to be held September 4-8, 2012. "The neuromodulation...

2012-07-18 02:26:38

NATICK, Mass., July 18, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has presented results of two studies evaluating the Infinion(TM) 16 Percutaneous Lead, the world's first and only 16-contact percutaneous lead for spinal cord stimulation (SCS) therapy, and the Clik(TM) Anchor, an innovative locking system designed to secure and reduce unwanted migration of SCS leads. The research was presented at the International Spine Intervention Society (ISIS) 20th Annual Scientific...

2012-07-18 02:25:45

MINNEAPOLIS, July 18, 2012 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that effective July 11, 2012, EmblemHealth, one of the largest private insurance payers in the northeast U.S., began to cover percutaneous tibial nerve stimulation (PTNS) using its Urgent PC Neuromodulation System for the treatment of overactive bladder (OAB) and associated...

2012-06-07 08:31:09

Using rabies virus, researcher tracks inputs to dopamine neurons A genetically-modified version of the rabies virus is helping scientists at Harvard to trace neural pathways in the brain, a research effort that could one day lead to treatments for Parkinson's disease and addiction. As described in a paper published on June 7 in the journal Neuron, a team of researchers led by Associate Professor of Molecular and Cellular Biology Naoshige Uchida used the virus to create the first-ever...